Endrin


Curated chemical-gene interactions from CTD
Entrez gene IDGene symbolInteraction typeReference
1050 CEBPA Affects expression PMID:10385688; PMID:34801515
1050 CEBPA Decreases activity PMID:10385688
1051 CEBPB Increases expression PMID:34801515
1052 CEBPD Increases expression PMID:34801515
1555 CYP2B6 Increases expression PMID:15548381
1576 CYP3A4 Increases expression PMID:15548381
1592 CYP26A1 Increases expression PMID:15589975
2099 ESR1 Increases activity PMID:15064155; PMID:26022396; PMID:26139245; PMID:16626760
2100 ESR2 Affects activity PMID:16626760; PMID:26139245
2194 FASN Increases expression PMID:34801515
2908 NR3C1 Increases activity PMID:19927138
2936 GSR Increases activity PMID:2276583
3320 HSP90AA1 Increases expression PMID:8792849
4790 NFKB1 Affects activity PMID:10385688
5468 PPARG Affects expression PMID:10385688; PMID:34801515
5915 RARB Increases expression PMID:15589975
5916 RARG Increases activity PMID:30639747
5916 RARG Increases expression PMID:15589975
6517 SLC2A4 Increases expression PMID:34801515
8856 NR1I2 Increases activity PMID:15548381; PMID:16054614; PMID:21115097
9370 ADIPOQ Increases expression PMID:34801515
9970 NR1I3 Increases activity PMID:28927721

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.